Compound Interactions
The combination of these three compounds is intended to target multiple pathways. Clenbuterol acts on beta-2 receptors, T3 influences thyroid hormone activity, and yohimbine affects alpha-2 adrenergic receptors. The combined effect is a result of the individual actions of each component.
Each ingredient has its own distinct pharmacology, and the combined effect of the blend is not necessarily the sum of its parts.
Medical and Research References
Each component has been studied in medical and research contexts. Official resources provide background on their classification and potential effects.